Prostate cancer is one of the most common cancers affecting men around the world. It develops in the prostate, a small gland ...

Prostate cancer is one of the leading causes of cancer-related death in men, and some experts project the number of cases to rise over the coming decades. But in a recent Urologic Oncology article, ...

Prostate cancer is the most commonly diagnosed cancer in the UK. But screening is not universal, and charities are divided over whether it should be extended. What do those living with the disease ...

About 60% of low‑risk prostate cancer patients are opting for active surveillance — and long‑term survival remains high.

AUSTIN (KXAN) — More people have been diagnosed with prostate cancer following years of decline. In a recent annual report from the American Cancer Society, it said that the statistics for prostate ...

The new drug, known as VIR-5500, uses a so-called cloaking device and only activates when it reaches the tumour ...

This article was reviewed by Darragh O’Carroll, MD. PSA and Testosterone: Are They Linked? Prostate-specific antigen (PSA) is a term you’ll probably become familiar with once you start getting ...

Prostate cancer screening compares favorably to screening for breast cancer in identifying significant cancers, reducing ...

Increasing use of blood tests to detect prostate cancer is leading to overworked doctors. NTNU has now created an AI diagnostic tool that can help lighten the burden.

FDA approves Pylarify TruVu, a new prostate cancer PET imaging agent designed to expand access and improve detection of recurrent or metastatic disease.